Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;88(9):909-20.
doi: 10.1007/s00109-010-0629-y. Epub 2010 May 8.

Inhibition of foam cell formation using a soluble CD68-Fc fusion protein

Affiliations

Inhibition of foam cell formation using a soluble CD68-Fc fusion protein

Karin Daub et al. J Mol Med (Berl). 2010 Sep.

Abstract

The appearance of lipid-rich foam cells is a major feature of vulnerable atherosclerotic plaque formation. The transformation of macrophages into foam cells results from excessive uptake of cholesterol-rich particles by scavenger receptors such as CD68. We cloned a CD68-Fc immunoadhesin, a fusion protein consisting of the extracellular domain of the human CD68 and a human Fc domain, and investigated the function in vitro. Specific binding of CD68-Fc to OxLDL with an affinity of 10 nmol/L was determined by surface plasmon resonance and increased binding to lipid-rich human and ApoE(-/-) mice plaque tissue. This was confirmed both by immunohistochemical staining of CD68-Fc-treated paraffin sections from human plaques and by ELISA-based quantification of CD68-Fc binding to human atherosclerotic plaque extracts. In an in vitro model of macrophage/foam cell formation, CD68-Fc reduced foam cell formation significantly. This was caused both by interference of CD68-Fc with OxLDL uptake into macrophages and platelets and by the inhibition of platelet/OxLDL phagocytosis. Finally, expression of metalloproteinases by macrophages/foam cells was inhibited by CD68-Fc. In conclusion, CD68-Fc seems to be a promising new tool for preventing macrophage/foam cell formation. Thus, CD68-Fc might offer a novel therapeutic strategy for patients with acute coronary syndrome by modulating the generation of vulnerable plaques.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Circulation. 2004 Feb 17;109(6):790-6 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1702-11 - PubMed
    1. Nat Clin Pract Cardiovasc Med. 2005 Jun;2(6):309-15 - PubMed
    1. Circulation. 2000 Mar 14;101(10):1091-6 - PubMed
    1. Nat Rev Drug Discov. 2003 Jan;2(1):52-62 - PubMed

Publication types

MeSH terms

LinkOut - more resources